Frenquency of Bacterial Vaginosis in Women of Reproductive Age From 13 To 40 Years
Keywords:
STIs, Vaginal infections, Women, Bacterial vaginosisAbstract
The aim of this study was to determine the frequency of Bacterial Vaginosis in women of childbearing age treated at the Kwanza Norte Maternal and Child Hospital between October 2023 and March 2024. The methodology adopted was a descriptive cross-sectional observational study, with a quantitative approach, using diagnostic, statistical and mathematical methods to obtain and analyze the data. The results showed that of the 482 patients evaluated, 196 (41%) tested positive for Bacterial Vaginosis, while 286 (59%) had negative results. In terms of age distribution, the 17-20 and 29-32 age groups had the highest incidence, with 29 cases each (18%). The peak was in January 2024, with 45 cases (22.9%), followed by December 2023, with 38 cases (19.3%). As for the origin of the patients, the Imbondeiros and Sambizanga neighborhoods were the most affected, with 21 (10.7%) and 18 cases (9.3%), respectively, while the Carreira de Tiro and Estação neighborhoods had the lowest numbers, with 6 cases each (3%). Among the types of vaginal infections, Bacterial Vaginosis was the most prevalent, with 116 cases (59%), followed by Candidiasis (45 cases; 23%) and Vaginal Trichomoniasis (35 cases; 18%). It can be concluded that Bacterial Vaginosis represents a significant public health problem, requiring preventive measures and effective control strategies.
Downloads
References
Abrão H. (1889).Vaginose bacteriana e Gardnerella vaginalis. DST – J Brás Doenças Sex Transm 1989; 1(2): 67-69.
ALLSWORTH, J. E.; PEIPERT, J. F. Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstetrics & Gynecology, v. 109, n. 1, p. 114-120, 2007.
Anderson, M.R.; & Friedland, S. (2004). Are vaginal symptoms ever normal? A review of the literature. Med Gen Med; New York, v.6: p.49-53, 2004.
Anukam, K C.; &; Olise, N.(2014). Evaluation of bacterial vaginosis (BV) using Nugent scoring system. J Med Biomed Res, 13(1), 25-32, 2014
Aroutcheva, A. et al. (2001). Defense factors of vaginal lactobacilli. Am J Obstet Gynecol; Saint Louis, v.185, n.2: p.375, 2001.
Backer, E. D.; & Verhelst, R.. et al. (2007). Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiology, 7:115, 2007
Bagnall, P.;& Rizzolo D.; (2018). Bacterial vaginosis: A practical review. Publish ahead– of-print., 2017.
BATES, B. Bates' Guide to Physical Examination and History Taking. 8. ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
Bates, S.(2003). Vaginal discharge. Curr. Obstet. Gynaecol. v.13, p.218- 223, 2003.
Bautista, C. T.;(2014). Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Military Medical Research, 3(1), 4, 2016
Boyle, D. C.; & Barton S. E.; et al. (2023).Is bacterial vaginosis associated with cervical intraepithelial neoplasia? Int J Gynecol Cancer, 13, 159– 163, 2003
Brotman, R. M. et al(2014). Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14:471,.
Copetti, N. (2004). Manual de Técnicas citológicas da Faculdade de Medicina da UFRGS. Porto Alegre: UFRGS, 2004. 31 p.
FREDRICKS, D. N.; FIEDLER, T. L.; MARRA, C. M. (2019). Molecular identification of bacteria associated with bacterial vaginosis. New England Journal of Medicine, v. 353, n. 18, p. 1899-1911.
HILLIER, S. L.; KLEBANOFF, S. J.; ESCHENBACH, D. A. (2021). Bacterial vaginosis: advances in pathogenesis, diagnosis, and treatment. Clinical Microbiology Reviews, v. 8, n. 4, p. 593-621.
Polattif .F. (2012). Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol, 7(1), 36–40, 2012
Porto, A.G.M. (2000). Infecções sexualmente transmissíveis na gravidez. Rio de Janeiro: Atheneu, 2000.
Rebuças, K.; & Junior. J. L.. et al (2014). Influence of human papillomavirus infection on the vaginal microbiome of women with immunocompetency. DST - J bras Doenças Sex Transm, 26,(1-4), 5-9, 2014.
REID, G.; HOWLETT, J.; MCBROOM, T. (2023). Lactobacillus and bifidobacterium therapy in women: efficacy and safety. International Dairy Journal, v. 11, n. 8, p. 817-822, 2001.
VERSTRAELEN, H.; SWIDSINSKI, A. (2022). The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Current Opinion in Infectious Diseases, v. 26, n. 1, p. 86-89, 2013.
